Defining patients at risk for neoplastic meningitis: what parameters can be used to determine who should be treated?
While a growing body of clinical research is defining how better to treat neoplastic meningitis, questions regarding which parameters can be used to define who to treat remain. This discussion initiates the clinical core and practical components of the symposium.